NovaBay Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
15.00
|
|
Average Rating
|
5.00
|
|
# Strong Buys
|
2
|
|
# Buys
|
0
|
|
# Holds
|
0
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-1.23
|
-3.50
|
-2.27
|
-184.55%
|
|
2022-06-30
|
-1.23
|
-1.40
|
-0.17
|
-13.82%
|
|
2022-03-31
|
-1.05
|
-0.05
|
1.00
|
95.24%
|
|
2021-12-31
|
-1.75
|
-0.70
|
1.05
|
60.00%
|
|
2021-09-30
|
-1.40
|
-1.75
|
-0.35
|
-25.00%
|
|
2021-06-30
|
-1.40
|
-1.40
|
0.00
|
0.00%
|
|
2021-03-31
|
-1.40
|
-1.40
|
0.00
|
0.00%
|
|
2020-12-31
|
-1.57
|
-1.40
|
0.17
|
10.83%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-4.95
|
|
2021-12-31
|
-5.25
|
|
2020-12-31
|
-1.69
|
|
2019-12-31
|
-0.52
|
|
2018-12-31
|
-0.38
|
|
2017-12-31
|
-0.51
|
|
2016-12-31
|
-2.05
|
|
2015-12-31
|
-7.01
|
|
2014-12-31
|
-7.75
|
|
2013-12-31
|
-10.50
|
|
2012-12-31
|
-5.93
|
|
2011-12-31
|
-124.92
|
|
2010-12-31
|
-4.50
|
|
2009-12-31
|
2.88
|
|
2008-12-31
|
-9.50
|
|
2007-12-31
|
-86.41
|